These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 29395659)

  • 1. Adiponectin: A potential therapeutic target for metabolic syndrome.
    Ghadge AA; Khaire AA; Kuvalekar AA
    Cytokine Growth Factor Rev; 2018 Feb; 39():151-158. PubMed ID: 29395659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of adiponectin as a potential therapeutic strategy.
    Lim S; Quon MJ; Koh KK
    Atherosclerosis; 2014 Apr; 233(2):721-728. PubMed ID: 24603219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction.
    Achari AE; Jain SK
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.
    Lara-Castro C; Fu Y; Chung BH; Garvey WT
    Curr Opin Lipidol; 2007 Jun; 18(3):263-70. PubMed ID: 17495599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and Perspectives.
    Yanai H; Yoshida H
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30857216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin and cardiovascular disease: mechanisms and new therapeutic approaches.
    Siasos G; Tousoulis D; Kollia C; Oikonomou E; Siasou Z; Stefanadis C; Papavassiliou AG
    Curr Med Chem; 2012; 19(8):1193-209. PubMed ID: 22257055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk.
    Matsuda M; Shimomura I
    Horm Mol Biol Clin Investig; 2014 Aug; 19(2):75-88. PubMed ID: 25390017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes: a literature review.
    Frankenberg ADV; Reis AF; Gerchman F
    Arch Endocrinol Metab; 2017 Dec; 61(6):614-622. PubMed ID: 29412387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin in diabetes mellitus.
    Xita N; Tsatsoulis A
    Curr Med Chem; 2012; 19(32):5451-8. PubMed ID: 22876922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The biological function of trophology, biological reactions of exo- and endotrophy the pathogenesis of metabolic syndrome, leptin and adiponectin: a lecture].
    Titov VN
    Klin Lab Diagn; 2014 Jun; (6):27-38. PubMed ID: 25335398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemin therapy suppresses inflammation and retroperitoneal adipocyte hypertrophy to improve glucose metabolism in obese rats co-morbid with insulin-resistant type-2 diabetes.
    Ndisang JF; Jadhav A
    Diabetes Obes Metab; 2013 Nov; 15(11):1029-39. PubMed ID: 23731386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adiponectin in health and disease.
    Oh DK; Ciaraldi T; Henry RR
    Diabetes Obes Metab; 2007 May; 9(3):282-9. PubMed ID: 17391153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adiponectin: a new link between obesity, insulin resistance and cardiovascular disease].
    Palomer X; Pérez A; Blanco-Vaca F
    Med Clin (Barc); 2005 Mar; 124(10):388-95. PubMed ID: 15766512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Adiponectin in Maintaining Metabolic Homeostasis.
    Adiyaman SC; Ozer M; Saydam BO; Akinci B
    Curr Diabetes Rev; 2020; 16(2):95-103. PubMed ID: 31267874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of leptin/adiponectin ratio in metabolic syndrome and diabetes.
    López-Jaramillo P; Gómez-Arbeláez D; López-López J; López-López C; Martínez-Ortega J; Gómez-Rodríguez A; Triana-Cubillos S
    Horm Mol Biol Clin Investig; 2014 Apr; 18(1):37-45. PubMed ID: 25389999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary regulation of nuclear receptors in obesity-related metabolic syndrome.
    Kawada T; Goto T; Hirai S; Kang MS; Uemura T; Yu R; Takahashi N
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():126-30. PubMed ID: 18296319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?
    Fisman EZ; Tenenbaum A
    Cardiovasc Diabetol; 2014 Jun; 13():103. PubMed ID: 24957699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.